XASXBCT
Market cap2mUSD
Sep 27, Last price
0.00AUD
Name
Bluechiip Ltd
Chart & Performance
Profile
Bluechiip Limited engages in the development and commercialization of a wireless tracking solution for the healthcare and life science, security, defense, and manufacturing industries. The company offers sample storage products, which include Bluechiip Enabled CryoVials; Bluechiip Enabled CryoBoxes; Bluechiip Enabled CryoTags; and accessories for sample management needs. It also provides readers comprising Bluechiip Enabled Handheld Readers, Bluechiip Enabled Multivial Readers, and Bluechiip Enabled CryoBox Trackers. In addition, the company offers sample management software, such as Stream Sample Manager that is designed to work seamlessly with Bluechiip Enabled readers and sample storage. Bluechiip Limited was incorporated in 2003 and is headquartered in Scoresby, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 485 -47.03% | 915 -1.32% | 927 1,713.40% | |||||||
Cost of revenue | 1,167 | 5,603 | 3,791 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (682) | (4,688) | (2,864) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (821) | (935) | (793) | |||||||
Tax Rate | ||||||||||
NOPAT | 139 | (3,753) | (2,071) | |||||||
Net income | (5,813) 15.31% | (5,041) 64.78% | (3,059) -5.21% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 3,828 | 2,437 | (3) | |||||||
BB yield | -64.77% | -18.89% | 0.02% | |||||||
Debt | ||||||||||
Debt current | 661 | 721 | ||||||||
Long-term debt | 194 | 171 | ||||||||
Deferred revenue | 1,123 | |||||||||
Other long-term liabilities | 49 | 42 | (976) | |||||||
Net debt | 683 | (831) | (2,751) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (5,008) | (4,209) | (3,167) | |||||||
CAPEX | (92) | (71) | ||||||||
Cash from investing activities | (92) | (71) | ||||||||
Cash from financing activities | 3,549 | 3,252 | (2) | |||||||
FCF | 317 | (5,206) | (882) | |||||||
Balance | ||||||||||
Cash | 172 | 1,723 | 2,751 | |||||||
Long term investments | ||||||||||
Excess cash | 148 | 1,677 | 2,704 | |||||||
Stockholders' equity | 709 | 2,364 | 4,362 | |||||||
Invested Capital | 1,337 | 1,536 | 1,805 | |||||||
ROIC | 9.69% | |||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 1,182,040 | 614,324 | 631,049 | |||||||
Price | 0.01 -76.19% | 0.02 -22.22% | 0.03 -34.15% | |||||||
Market cap | 5,910 -54.19% | 12,901 -24.28% | 17,038 -33.73% | |||||||
EV | 6,593 | 12,070 | 14,288 | |||||||
EBITDA | (556) | (4,644) | (2,856) | |||||||
EV/EBITDA | ||||||||||
Interest | 126 | 30 | ||||||||
Interest/NOPBT |